Nearly 20 lakhs patients die of heart diseases annually in India out of which 50% are related to tobacco consumption
Children face a greater risk than adults of the negative effects of second-hand or Passive smoking says Health Experts at Gleneagles Global Health City, Chennai
Chennai, 30 th May, 2018: On the occasion of ‘World No Tobacco Day’31 st May 2018, Gleneagles Global
Hospitals, a Parkway Pantai Enterprise releases its month long creative campaign ‘S.O.O.N – Quit
Tobacco’, in continuation with its last year’s initiative on this day.
S.O.O.N symbolizes Save Our Organs Now and this year’s theme of ‘World No Tobacco Day’ being
‘Tobacco and heart disease’, the campaign by Gleneagles Global Hospitals focuses on the impact that
tobacco has on the cardiovascular health of people all over the world. Through the nationwide campaign
of S.O.O.N, the hospital aims to increase awareness on feasible actions and measures that people can
take to reduce the risks to heart health posed by tobacco.
Global Health City, Chennai is offering a month long health screening programme to nudge you towards
quitting smoking and tobacco, wherein the health of heart and lungs will be assessed step towards along
with consultation from a Pulmonologist. This screening will be a step towards bringing back healthy life
to the smokers and tobacco users. For further details Pleases call – 1800 123 1111.
“Nearly 20 lakh patients die of heart diseases annually in India, out of which possibly 50% are related to
tobacco, apart from 4-5 lakh deaths which are due to tobacco intake related cancers” said Dr
Ravikumar, Senior Cardiologist and Associate Director – Heart Failure Programme, Gleneagles Global
Health City. He further added “With such huge mortality figures staring at us, and related to a single
substance addiction, it’s only natural that this is the responsibility of the medical community to raise our
voices against tobacco intake”.
Nearly 120 million Indian adults smoke, placing India second in number of smokers. According to the
data from World Health Organization (WHO), the deaths related to cardiovascular diseases (CVD) is
more than any other cause of death worldwide. Smoking caused about 1 million deaths in 2010 and
about 70% of these deaths occurred at the ages of 30–69 years. Tobacco use and second-hand smoke
exposure contributes to approximately 12% of all heart disease deaths. Additionally, consumption of
tobacco is the second leading cause of cardio vascular disease, after high blood pressure. Each year,
globally, 7 million people are the victims of the tobacco epidemic and close to 9 lakhs are non-smokers
who die from breathing second-hand smoke.
Tobacco use is one of the leading public health challenges the world faces today, with India being one of
the largest consumers of tobacco in the World says Dr VijilRahulan, Head of Department – Pulmonary
Medicine, Gleneagles Global Health City. The problem is further alarming due to the fact that
adolescents and children are particularly vulnerable to tobacco use or rather abuse. According to recent
reports, Tobacco smoke holds almost 4,000 harmful chemicals. Every time one smokes, these go into the
lungs, bloodstream and body tissues, increasing the risk of developing lung diseases, coronary heart
disease, stroke or cancer added Dr VijilRahulan According to Dr Rajasundaram, Director-Institute of Oncology, Surgical Oncologist, Gleneagles Global
Health City, “Children face a greater risk than adults of the negative effects of second-hand or passive
smoking. When the air is tainted with cigarette smoke, young, developing lungs receive a higher
concentration of inhaled toxins than do older lungs because a child'sbreathing rate is faster than that of
adults. When non-smokers too get affected by this evil in equal measure, we should know it is time for us
to raise our hands and voice against tobacco”
About Global Health city- The sprawling, 21-acre facility in Perrumbakkam, Chennai is the largest facility
of Gleneagles Global Hospitals India. With over 1000-beds and accreditations from leading agencies, the
facility is one of the best for advanced healthcare in India. The hospital offers the end-to-end spectrum
of advanced healthcare facilities as well as excellent facilities for research and advanced education. The
hospital has undertaken several path-breaking liver, heart, lung and kidney procedures.
Accredited and recognized by several international and national level accrediting agencies, it is a
healthcare destination of choice for both people in India and worldwide. World-class infrastructure,
dedicated staff and a commitment for medical excellence are the USPs of this Global Hospital facility.
The hospital has several achievements to its credit and continues to work on several pioneering
About Gleneagles Global Hospitals, a Parkway Pantai Enterprise: Gleneagles Global Hospitals is part of
Parkway Pantai, a fully owned subsidiary of IHH Healthcare. In India, Gleneagles Global Hospitals
operates a chain of multi-super specialty hospitals offering tertiary and quaternary healthcare services
with over 2,000 beds and state-of the-art, world-class hospitals in Hyderabad, Chennai, Bangalore and
Mumbai. A pioneer in kidney, liver, heart and lung transplants, Gleneagles Global Hospitals provides
comprehensive multi-organ transplant services in the country.
Gleneagles Global Hospitals aims to strengthen and expand its leading market position as a destination
for multi-organ transplant for patients from India, Middle East, Africa and South East Asia. We are
committed to further our aspiration of making quality health care more accessible to all.